These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33541414)

  • 1. Mesenchymal stromal cells as prophylaxis for graft-versus-host disease in haplo-identical hematopoietic stem cell transplantation recipients with severe aplastic anemia?-a systematic review and meta-analysis.
    Li R; Tu J; Zhao J; Pan H; Fang L; Shi J
    Stem Cell Res Ther; 2021 Feb; 12(1):106. PubMed ID: 33541414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Haploidentical Hematopoietic Stem Cell Transplantation with Umbilical Cord-Derived Mesenchymal Stem Cells in Patients with Severe Aplastic Anemia: A Retrospective Controlled Study.
    Sheng XF; Li H; Hong LL; Zhuang H
    Turk J Haematol; 2022 Jun; 39(2):117-129. PubMed ID: 35448935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infusion of haploidentical hematopoietic stem cells combined with mesenchymal stem cells for treatment of severe aplastic anemia in adult patients yields curative effects.
    Ding L; Han DM; Zheng XL; Yan HM; Xue M; Liu J; Zhu L; Guo ZK; Mao N; Ning HM; Wang HX; Heng Zhu
    Cytotherapy; 2022 Feb; 24(2):205-212. PubMed ID: 34799271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - A meta analysis.
    Geng C; Liu X; Chen M; Yang C; Han B
    Leuk Res; 2020 Jan; 88():106266. PubMed ID: 31743865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results.
    Liu Z; Zhang Y; Xiao H; Yao Z; Zhang H; Liu Q; Wu B; Nie D; Li Y; Pang Y; Fan Z; Li L; Jiang Z; Duan F; Li H; Zhang P; Gao Y; Ouyang L; Yue C; Xie M; Shi C; Xiao Y; Wang S
    Bone Marrow Transplant; 2017 May; 52(5):704-710. PubMed ID: 28067873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia.
    Onishi Y; Mori T; Yamazaki H; Hiramoto N; Zaimoku Y; Kanaya M; Matsue K; Onizuka M; Aotsuka N; Uchida N; Onodera K; Kanda J; Nakamae H; Yamamoto R; Kuriyama T; Kimura T; Ichinohe T; Atsuta Y;
    Transplant Cell Ther; 2023 Dec; 29(12):766.e1-766.e8. PubMed ID: 37730121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of human leukocyte antigen-haploidentical hematopoietic stem cells transplantation combined with allogenic mesenchymal stem cell infusion for treatment of severe aplastic anemia in pediatric and adolescent patients.
    Ding L; Han DM; Zheng XL; Yan HM; Xue M; Liu J; Zhu L; Li S; Mao N; Guo ZK; Ning HM; Wang HX; Zhu H
    Stem Cells Transl Med; 2021 Feb; 10(2):291-302. PubMed ID: 32978903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing outcomes for haploidentical hematopoietic stem cell transplantation in severe aplastic anemia with intensive GVHD prophylaxis: a review of current findings.
    Xu ZL; Huang XJ
    Expert Rev Hematol; 2021 May; 14(5):449-455. PubMed ID: 33945370
    [No Abstract]   [Full Text] [Related]  

  • 9. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
    Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between haploidentical hematopoietic stem cell transplantation combined with an umbilical cord blood unit and graft-
    Yao D; Tian Y; Li J; Li B; Lu J; Ling J; Zheng D; Yao Y; Xiao P; Meng L; Hu S
    Ther Adv Hematol; 2022; 13():20406207221134409. PubMed ID: 36324490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-derived marrow mesenchymal stromal cell co-transplantation following a haploidentical hematopoietic stem cell transplantation trail to treat severe aplastic anemia in children.
    Wang Z-; Yu H-; Cao F-; Liu Z-; Liu Z-; Feng W-; Liu X-; Yu Y-; Xiao Y; Li L-; Zhou J
    Ann Hematol; 2019 Feb; 98(2):473-479. PubMed ID: 30341538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease-a meta-analysis.
    Morata-Tarifa C; Macías-Sánchez MDM; Gutiérrez-Pizarraya A; Sanchez-Pernaute R
    Stem Cell Res Ther; 2020 Feb; 11(1):64. PubMed ID: 32070420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia.
    Xu L; Liu Z; Wu Y; Yang X; Cao Y; Li X; Yan B; Li S; Da W; Wu X
    Eur J Med Res; 2018 Mar; 23(1):12. PubMed ID: 29490698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Haploidentical Hematopoietic Stem Cell Transplant With or Without Unrelated Cord Blood Infusion in Severe Aplastic Anemia: Outcomes of a Multicenter Study.
    Lei M; Zhang Y; Jiao W; Li X; Zhou H; Wang Q; Qiu H; Tang X; Han Y; Fu C; Jin Z; Chen S; Sun A; Miao M; Liu L; Wu D
    Front Immunol; 2022; 13():912917. PubMed ID: 35812409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemia.
    Zhao J; Ma L; Zheng M; Su L; Guo X
    Ann Hematol; 2023 Sep; 102(9):2565-2587. PubMed ID: 37442821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia.
    Lu Y; Sun RJ; Zhao YL; Xiong M; Cao XY; Zhang JP; Wei ZJ; Zhou JR; Liu DY; Lu DP
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1881-1887. PubMed ID: 29772350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Haploidentical Hematopoietic Stem Cell Transplantation with Co-Infusion of Mesenchymal Stromal Cells for Acquired Severe Aplastic Anemia: A Report of 127 Cases].
    Han DM; Ding L; Zheng XL; Yan HM; Xue M; Liu J; Zhu L; Li S; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1230-1237. PubMed ID: 35981390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of Frontline Haploidentical Hematopoietic Stem Cell Transplantation and Salvage Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia].
    Xiao F; Liu Q; Fan D; Guo HX; Yan XQ; Zhao H; Liu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1683-1688. PubMed ID: 33067974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of upfront haploidentical hematopoietic stem cell transplantation and salvage haploidentical hematopoietic stem cell transplantation after immunosuppressive therapy in children with acquired severe aplastic anemia - a multicenter study.
    Luo D; Qu Y; Wang D; Zhang B; Sun M; Xiong H; Lu J; Yang R; Zhao M; Liu H; Jiang H
    Front Immunol; 2024; 15():1384640. PubMed ID: 38720904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA.
    Zu Y; Zhou J; Fu Y; Fang B; Liu X; Zhang Y; Yu F; Zuo W; Zhou H; Gui R; Li Z; Liu Y; Zhao H; Zhang C; Song Y
    Sci Rep; 2021 Jan; 11(1):253. PubMed ID: 33420287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.